270 related articles for article (PubMed ID: 10636548)
1. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology.
Ortapamuk H; Ozmen MM; Ibis S; Naldöken S; Aksoy F
Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548
[TBL] [Abstract][Full Text] [Related]
2. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
Taillefer R; Robidoux A; Turpin S; Lambert R; Cantin J; Léveillé J
J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
[TBL] [Abstract][Full Text] [Related]
3. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases.
Mansi L; Rambaldi PF; Procaccini E; Gregorio FD; Laprovitera A; Pecori B; Vecchio WD
Eur J Nucl Med; 1996 Aug; 23(8):932-9. PubMed ID: 8753682
[TBL] [Abstract][Full Text] [Related]
4. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
[TBL] [Abstract][Full Text] [Related]
5. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
[TBL] [Abstract][Full Text] [Related]
7. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
[TBL] [Abstract][Full Text] [Related]
8. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
9. Detection of malignant breast tumours in dense breast tissue: results of 99mTc-tetrofosmin scintimammography related to surgery.
Bongers V; Borel Rinkes IH; Sie-Go DM; Pijnappel R; de Hooge P; van Rijk PP
Eur J Surg Oncol; 1999 Apr; 25(2):152-6. PubMed ID: 10218457
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement.
Jaukovic LDj; Ajdinovic BZ; Jankovic ZD; Strbac M
Nucl Med Rev Cent East Eur; 2006; 9(1):30-6. PubMed ID: 16791801
[TBL] [Abstract][Full Text] [Related]
11. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
Akçay MN; Akin Y; Karabağ B; Ozcan O; Oren D
Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644
[TBL] [Abstract][Full Text] [Related]
12. The role of (99m)Tc-tetrofosmin pinhole-SPECT in breast cancer non palpable axillary lymph node metastases detection.
Spanu A; Tanda F; Dettori G; Manca A; Chessa F; Porcu A; Falchi A; Nuvoli S; Madeddu G
Q J Nucl Med; 2003 Jun; 47(2):116-28. PubMed ID: 12865872
[TBL] [Abstract][Full Text] [Related]
13. The use of scintimammography for detecting the recurrence of loco-regional breast cancer: histopathologically proven results.
Bongers V; Perre C; de Hooge P
Nucl Med Commun; 2004 Feb; 25(2):145-9. PubMed ID: 15154703
[TBL] [Abstract][Full Text] [Related]
14. Axillary lymph node metastases detection with 99mTc-sestamibi scintimammography in patients with breast cancer undergoing curative surgery.
Lumachi F; Ferretti G; Povolato M; Bui F; Cecchin D; Marzola MC; Zucchetta P; Basso U
Anticancer Res; 2007; 27(4C):2949-52. PubMed ID: 17695476
[TBL] [Abstract][Full Text] [Related]
15. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
16. 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis.
Arslan N; Oztürk E; Ilgan S; Urhan M; Karaçalioglu O; Pekcan M; Tufan T; Bayhan H
Nucl Med Commun; 1999 Apr; 20(4):317-25. PubMed ID: 10319351
[TBL] [Abstract][Full Text] [Related]
17. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of 99m-Tc-sestamibi scintimammography in suspected breast cancer and in axillary lymph node metastases detection.
Lumachi F; Ferretti G; Povolato M; Marzola MC; Zucchetta P; Geatti O; Bui F; Brandes AA
Eur J Surg Oncol; 2001 Apr; 27(3):256-9. PubMed ID: 11373101
[TBL] [Abstract][Full Text] [Related]
19. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C
Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]